Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who followed a protective diet and those on a standard hospital diet had a similar likelihood of infections.
Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.
UPDATE: On October 25, the FDA approved Tecvayli (teclistamab) to treat some people with multiple myeloma.
In 2009, March was declared Myeloma Awareness Month (MAM).
An experimental drug saved his life and inspire him to connect others with cancer to bone marrow transplants and clinical trials.
After treatment for multiple myeloma, Bryon Daily pays it forward to other African Americans, who are at higher risk for this cancer.
It’s a different life—cancer changes you—but it can be a good one.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
There are many ways to get smarter in this issue.
Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.
98% of people who received the customized immunotherapy responded to the one-time treatment.
Screening high-risk groups could improve the survival of patients who develop myeloma.
Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.
People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.